Executive Board

orange__line

At MedSIR, we scout for the best strategic ideas and set the wheels in motion to development them into game-changing clinical trials in oncology.

  • MARIA CAMPOS

    MARIA CAMPOS

    Strategic Director

    María Campos earned her undergraduate degree in Pharmacy at the University of Barcelona followed by a Degree in Quality Assurance from the American Society of Quality Control and since then began her career of now more than 20 years in the Clinical Research field.

    Maria has spent the bulk of the last two decades in the Oncology field in both US and European Pharmaceutical Companies, with the majority of her time spent in solid tumors (lung and breast cancer) and in liquid tumors such as Non-Hodgkin’s disease and Myeloma.

    Over these years Maria developed a strong interest for the development of pharmacological treatments with a special focus on the optimization and innovation of traditional drug developmental processes in order to help increase efficiency and success rates of new molecules in the “fight against cancer”. In 2012, with this goal and dream in mind, Maria helped found, together with experts in Oncology, the company called Medica Scientia Innovation Research (MedSIR) and currently holds the position of Scientific Director.

    Maria is very well-travelled and speaks Catalan, Spanish and English fluently and has working knowledge of French.

  • ALICIA GARCÍA

    ALICIA GARCÍA

    Operations Director

    Alicia has both academic and drug development experience. On the academic side, she obtained her PhD degree in neuropharmacology and afterwards continued her post-doctoral career in pre-clinical research at the Cardiology Unit at Vall d’Hebron and Neurobiology department at the University of Barcelona.

    In drug development, Alicia started her career in clinical research at Bayer. From there she moved to positions of increasing responsibilities in different biopharma companies (Almirall, Jassen Pharmaceutica, Merck Serono and Novartis) where she was involved in the management of key clinical trials in the development of drugs such as aclidinium (COPD), bortezomib (multiple myeloma) or in the global team responsible for the development of safinamide (Parkinson’s disease). Main therapeutic areas of expertise include Oncology, Neurology and Respiratory as well as Vaccines and Fertility.

    Alicia has broad experience encompassing the entire spectrum of drug development from the early clinical to the latest phases including launch and phase IV clinical studies, with robust knowledge and overall vision of the multiple aspects involved in clinical research. She has proven ability to lead large, multinational and cross-functional teams.

    She enjoys working in an international, diverse and dynamic environment and is passionate to take on new challenges and keep learning.

MedSIR is always looking to add talented individuals to its team in a number of roles. If you are interested in getting us to know you better, please visit our Careers page to submit your CV to us.

Careers 01
Careers 02
Careers 03